Neuren Pharmaceuticals LimitedASX: NEU

Positive FDA meetings enable INDs for three Phase 2 trials

Jun 1, 2021 at 3:33 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment